Volume 16 Supplement 1
Evaluation of cardiac masses by CMR: a tertiary center experience of cases presenting with suspicion of mass by echo or CT
© Tumma et al.; licensee BioMed Central Ltd. 2014
Published: 16 January 2014
To evaluate the effectiveness of Cardiac Magnetic Resonance Imaging (CMR) in evaluation of cardiac masses. Cardiac masses are a rare but important finding on cardiac imaging. Differentiating benign from malignant masses is crucial as an accurate diagnosis can affect the work up and management of the patient. To date very few studies have evaluated the effectiveness of CMR in aiding the diagnosis of mass found by echo or CT.
A retrospective review of CMR performed from January 2000 to June 2013 was conducted with waiver of consent which was approved by our institutional review board. Analysis of a total of 249 consecutive patients who underwent CMR for evaluation of mass found on echo or CT were included. Follow up care, including any pathology or future imaging, was then correlated to these findings. All patients underwent CMR on a 1.5 Tesla scanner with EKG gating following the same protocol.
Cardiac tumors, while rare, remain an important and technically difficult diagnosis to make by current imaging modalities. We demonstrate that CMR can play a key role in making an accurate diagnosis. In our consecutive case series, over 62% of patients referred for mass evaluation were found to have either no evidence of mass or benign anatomical variants, thus saving patients further invasive work up and potential radiation exposure. 75 patients with no evidence of mass or benign variants did not have further follow up at our institution. 65 patients who did have follow up, only one patient was noted to have a benign mass persistent on subsequent imaging, but missed on CMR due to artifact. CMR also provided 100% sensitivity in the evaluation of malignant masses, making it a very effective screening tool in an oncologic work up when indicated. CMR's ability to rule out mass and/or to identify benign anatomical variants which simulate mass on echo can be invaluable. Additionally, in the presence of a mass, CMR can provide accurate differentiation of benign and malignant lesions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.